AKT1 and neoplasm: ITZ has been demonstrated to elicit its antitumor effects by inhibiting tumor cells proliferation through multiple signaling pathways, including Wnt/β-catenin, Hedgehog, and PI3K/AKT/mTOR (8–10, 30, 31).